Health, Education & Government
›
Life Sciences & Pharma
›
Cell & Gene Therapy
Cell Therapy Logistics (Vein-to-Vein)
Regulated development and commercialization journeys where clinical, quality, and market access align.
Example organizations in this space:
Cryoport
BioLife Solutions
World Courier
Marken
This interactive experience is the shipped product itself — the same application code customers run in production, mounted read-only in your browser over a real sample journey. Not a video, not a mockup: because the demo and the product are one codebase, it can never drift from the real thing.
Inside this journey
-
Supply Chain Discovery
Map current transport flows, viability windows, regulatory constraints, stakeholders, and measurable success signals for cell therapy shipments.
Discovery Questions
A quick map of your current program
- Tell me briefly how your vein to vein flow is organized today, from collection site through manufacturing to return of therapy
- How many active collection locations does your program route from in a typical month?
- Which transportation modes do you currently use for patient cell material movement?
- Who on your team currently owns chain of identity and chain of custody for a shipment from collection to manufacture?
- When you think about last quarter, how often did a shipment miss its viability window or require intervention?
Where current process failures actually hurt patients and programs
- What single operational failure in your logistics process would force you to pause shipments immediately?
- Walk me through the last time you had a temperature excursion or delayed delivery, what happened and what downstream impact did it cause?
- How quickly do your teams detect and escalate a temperature, location, or identity exception today?
- Which handoff between parties tends to be the riskiest for your shipments, and why?
- Who in your leadership hears about logistics failures first, and how does that typically change the response?
Regulatory, identity, and custody concerns that keep you awake
- If a regulator audited a recent shipment, where would you expect the biggest documentation gap to appear?
- Describe how you currently prove chain of identity for each patient lot during transit
- How many regulatory or accreditation frameworks must your shipment processes satisfy right now?
- Which of these would be a fatal audit finding for your program if not resolved before commercial launch?
- Who on your team must sign off for a change to your logistics SOPs to be compliant?
What you are weighing instead of changing providers
- Which alternatives are you actively evaluating right now for vein to vein logistics?
- What would have to be true about your current approach for you to decide to keep it rather than move to an external specialty partner?
- Has anyone proposed solving this entirely in house, and if so, what aspects did they plan to own?
- What single business metric about the incumbent or internal option would need to change for you to switch this quarter?
- How does procurement evaluate operational risk versus cost when comparing alternatives?
Operational readiness and constraints we must confirm
- Who will own integrations and data feeds for tracking and shipment documentation on your side, and do they have API access rights?
- How many full time equivalents would you commit to onboarding and operational coordination during the two to four month rollout?
- Which systems must we integrate with for custody and release records?
- Are the collection sites and manufacturing facilities already approved to accept external couriers, or will site approvals be required?
- What legal or compliance reviews could extend your onboarding timeline beyond two months?
- Which infrastructure prerequisites, if missing, would stop the project before pilot shipments start?
- If a cross border permit or customs approval were delayed beyond your target, what is the maximum calendar delay you can absorb before patient timelines are impacted?
How you measure success and what acceptance looks like
- What specific acceptance criteria must a qualification shipment meet for you to greenlight live patient shipments?
- How do you quantify the cost of a failed shipment today, including patient, manufacturing, and regulatory impacts?
- If a pilot demonstrates target performance, what internal approvals would allow you to sign a commercial agreement within one week?
- Which monitoring thresholds are non negotiable for you to accept during live operations?
- Who will be the named owner accountable for go live acceptance on your side?
Real scenarios and edge cases we must simulate
- Describe a high risk route you operate, such as long international legs or rural pick ups, and the main pain points you see when it is active
- How many times per month do you plan for shipments that cross international borders with controlled substances or restricted materials?
- Which failure scenario would require immediate patient rescheduling rather than a contingency plan?
- Who at a collection site is enabled to delay a pick up for patient safety reasons, and how is that communicated?
- When a critical handoff fails, what is your preferred escalation path and timeline to resolve before patient care is affected?
Decision drivers and timeline to move forward
- If the qualification run proves the agreed KPIs, what is the single internal blocker that would still stop you from contracting immediately?
- Which commercial terms are most likely to slow approval, cost or liability allocation or SLAs and penalties?
- How soon do you need a pilot to start to meet your program launch dates?
- Who are the critical approvers whose calendars will determine whether we can meet that pilot start date?
- What would make you sign the agreement in the same week the pilot completes successfully?
- What is the best way for us to demonstrate low risk to your stakeholders during pilot and contracting?
-
Operational Walkthrough
Walk through how the proposed vein-to-vein logistics will operate in the buyer's real scenarios, highlighting handoffs, monitoring, and escalation points.
Solution Experience
- Operational Walkthrough — Vein-to-Vein Logistics
- Confirm the current state and its cost to your operations
- You confirm the demonstrated workflow removes the handoff and temperature failure modes you described in Discovery.
- Provide the top 10 collection-to-treatment site pairs and one representative cross-border route for qualification.
- You accept the proposed escalation decision points and time-to-resolution targets as sufficient to protect patient treatment windows.
- Walk through an end-to-end route using your real scenario
- Provide the acceptance criteria for test shipments including temperature ranges, allowable gaps in chain-of-custody documentation, and required regulatory deliverables.
- Agreement on the evidence and test shipments required to move to Test Shipments Evaluation.
- Show live monitoring and temperature control proof for the route
- Deliver a route-specific runbook and escalation matrix for the demoed route, including monitoring thresholds and notification endpoints, within 5 business days.
- Walk through escalation and customs exception handling
- Schedule a qualification test window and name the site readiness owners for the first pilot shipment.
- Validate alignment to your acceptance criteria
- Operational Walkthrough — Vein-to-Vein Logistics
- Solution Experience Deck — Operational Walkthrough
- Solution Brief — Operational Walkthrough
- meeting
- slides
- document
-
Solution Scope
Define services, responsibilities, regulatory deliverables, facility qualifications, and acceptance criteria for test and live shipments.
Scope Configuration
- Receive and Log Collection Kits
- Chain-of-Identity Labeling and Tamper Seals
- Controlled-Rate Freezing (Cryopreservation)
- Long-Term Cryostorage and Inventory
- Cryogenic Transport with GPS Temperature Monitoring
- Chain-of-Custody Documentation Package
- Cross-Border Customs Brokerage and Clearance
- Emergency Recovery and Rapid Replacement Shipment
- Receive and Reconcile Returned Patient Material
- Thaw-Ready Delivery and Infusion Documentation
- Deliver Audit-Ready Shipment Records
- Temperature-Excursion Investigation and Disposition Report
Scope Questions
Receive and Log Collection Kits
- Confirm whether your clinics ship manufacturer-supplied collection kits with a kit lot ID and packing manifest.
- Provide the primary patient identifier method used at collection (examples: wristband barcode, pre-barcoded tube label, handwritten ID).
- Identify the number of collection sites that will send kits to the receiving facility at go-live.
- List the receiving documentation your sites currently complete on kit arrival (receipt log, temperature record, kit integrity checklist).
- Estimate the average daily volume of kits to be received during the first 3 months.
Chain-of-Identity Labeling and Tamper Seals
- State whether dual-identifier labeling (patient plus treatment ID) is mandatory on primary containers.
- Indicate the tamper-evidence method you require (serialized tamper seal, cable tie, security label) and whether you need serialization recorded.
- For handoffs, describe the verification method you prefer (wristband scan, timestamped photo, signed manifest).
- During reconciliation failures, who is authorized to approve an exception and what documentation is required?
- Using your current labels, do barcode symbologies and human-readable IDs follow a standard your QA will accept?
Controlled-Rate Freezing (Cryopreservation)
- When controlled-rate freezing is performed, what run acceptance metrics do you record (end temperature, ramp rate, hold time)?
- Within what timeframe must required release assays be completed before freezing (hours)?
- Which assays are mandatory prior to freezing for your product (e.g., viability, identity PCR, mycoplasma)?
- How many batches per week do you expect to process under controlled-rate freezing?
- Do you supply freezing containers and cryoprotectant reagents or should we provide them?
Long-Term Cryostorage and Inventory
- Are vapor-phase liquid nitrogen conditions required, or are mechanical ultra-low freezer conditions acceptable for long-term storage?
- Who in your organization will be the approval authority for inventory disposition and transfer between storage locations (role/title)?
- Specify the initial inventory size in units and the expected annual growth rate.
- What LIMS identifiers do you use for samples (barcode patterns or accession formats) so we can map inventory records?
- Will you require scheduled inventory audits and what cadence (monthly, quarterly)?
Cryogenic Transport with GPS Temperature Monitoring
- In the event of qualification runs, list the measurable acceptance criteria you will use to confirm successful cryogenic transport (target temperature band, maximum cumulative excursion minutes, required telemetry sampling frequency).
- By what shipper hold-time and container type do you plan to move live patient material (state hours and container class)?
- Attach or describe your preferred alerting matrix for temperature deviation and geofence breach (who gets notified and how).
- Select the telemetry sampling interval you require for live shipments.
- Describe any transport legs you consider high-risk (long customs waits, remote transfers, airside transfers) so we can propose mitigations.
Chain-of-Custody Documentation Package
- Which documents must be included in the chain-of-custody package for each shipment (signed custody log, timestamped scans, raw telemetry CSVs, COA)?
- Does your QA require 21 CFR Part 11–compliant electronic signatures on custody records or are paper-signed records acceptable?
- If an excursion occurs during a qualification shipment, what threshold or evidence will you require to accept the lot (retest results, viability threshold percentage)?
- At which custody events do you require direct LIMS integration (scans at collection, receipt, release)?
- Which stakeholder roles should receive final custody-package delivery automatically (QA lead, manufacturing release, clinical operations)?
Cross-Border Customs Brokerage and Clearance
- Confirm the definitive list of export and import countries you expect to service in year one.
- Provide any known country-specific permit numbers or regulatory contacts that will accelerate customs clearance.
- Identify any commodity codes (HS codes) or biologics classifications you currently use for customs paperwork.
- List any temporary admission mechanisms you expect to use (ATA Carnet, temporary import) for re-use of shippers or components.
- Estimate typical customs delay durations on cross-border legs under current experience.
Emergency Recovery and Rapid Replacement Shipment
- State whether backup donor collections or reserved manufacturing slots exist to support rapid replacement shipments.
- Indicate the preferred expedited routing for emergency shipments (dedicated courier, charter, commercial flight priority).
- For emergency recovery, who is authorized to approve replacement dispatches and financial spend?
- During an emergency replacement, what customs or clinical documents are acceptable to enable rapid clearance?
- Using past incidents, which mitigation strategies have most effectively reduced time-to-replacement?
Receive and Reconcile Returned Patient Material
- When returned patient material arrives, which temperature log review criteria must be met before proceeding to reconciliation?
- Within how many hours must QA disposition be completed for returned materials under normal service levels?
- Which photographic and documentary evidence must be captured at receipt and attached to the LIMS record?
- How many signatories are required to accept returned material into inventory and release for manufacturing?
- Do you require we perform initial quarantine and holding in our facility pending your QA release?
Thaw-Ready Delivery and Infusion Documentation
- Are signed thaw verification records required from the clinical team prior to infusion?
- Who is responsible for training infusion center staff on thaw handling and infusion checklists (role/title)?
- Specify maximum allowable time from thaw completion to start of infusion.
- What bedside documentation must be provided with the thawed product (infusion checklist, patient ID confirmation, chain-of-identity scan)?
- Will you require traceability of thaw events into your LIMS or EHR and by what mechanism?
Deliver Audit-Ready Shipment Records
- In the event of a regulatory audit, what assembled record set and format will you accept as audit-ready within the agreed SLA?
- By what timeframe post-delivery must audit-ready records be made available (hours/days)?
- Attach or describe any record-formatting requirements (single consolidated PDF, individual CSVs, LIMS export) you mandate.
- Select which regulatory jurisdictions' expectations guide your record formatting and retention (for example list of authorities).
- Describe the preferred process for handling ad hoc audit inquiries and who should be the contact.
Temperature-Excursion Investigation and Disposition Report
- Which elements must be present in a temperature-excursion investigation report (telemetry timeline, personnel actions, root-cause analysis, corrective actions, disposition recommendation)?
- Does your regulatory program mandate external notifications for excursions that meet defined impact thresholds?
- If an excursion leads to potential patient impact, which notification templates and contacts should we use to accelerate reporting?
- At which excursion thresholds does your QA require immediate quarantine in LIMS pending disposition?
- Which roles must approve the final disposition (QA director, clinical lead, regulatory affairs) and who has final sign-off authority?
-
Test Shipments Evaluation
Run and evaluate qualification shipments against agreed acceptance criteria for temperature control, chain-of-custody, and documentation.
- decision_readiness
- stakeholders
- current_state
- desired_state
- success_criteria
- gaps
- decision_readiness
- gaps
- stakeholders
- success_criteria
- current_state
- desired_state
- current_state
- stakeholders
- gaps
- decision_readiness
- decision_readiness
- decision_readiness
- decision_readiness
- decision_readiness
-
Mutual Commit
Finalize commercial and contract terms, confirm regulatory responsibilities, and lock acceptance and escalation clauses for live operations.
Agreement Modules
- Master Services Agreement (MSA)
- Statement of Work (SOW)
- Order Form / Service Order
- Service Level Agreement (SLA)
- Acceptance and Escalation Addendum
- Regulatory Responsibilities Schedule
- HIPAA Business Associate Addendum (BAA)
- Insurance and Indemnity Schedule
- Change Order Agreement
- Termination and Exit Plan
- Integration and Credentials Agreement
-
Deployment
Operationalize rollout with readiness checks, execution, and outcome validation.
-
Pre-Deployment Readiness
Capture concrete readiness facts the rollout depends on — facility approvals, access, training owners, and cross-border documentation readiness.
Pre-Deployment Questions
Environment and site access
- Which rollout sites require deployment (list site name and city — one line per site). This feeds site-specific qualification modules.
- Do each of the listed sites currently hold the facility approvals required for live cell handling (FDA registration or local equivalent, AABB or equivalent accreditation)?
- For any site pending approval, list site name, missing approval type, and expected approval date (one line per site) — so we can schedule qualification tasks.
Data and documentation readiness
- Are the chain-of-identity and chain-of-custody document templates approved by your QA/regulatory owner for live operations?
- Provide the name and contact of the QA/regulatory approver who will sign these templates (name, role, email) — we use this to schedule the approval gate.
- Are cross-border customs and permit packages for each international route finalized and assigned an importer/exporter point of contact?
- If any routes are pending, list the route (origin→destination), outstanding document(s), and expected ready date (one line per route).
People and ownership
- For each deployment workstream—site qualification, training, customs coordination, monitoring integrations—provide the buyer-side owner (name, role, email). One line per workstream.
- Is there a named seller-side operational contact for day-to-day coordination during rollout?
- If yes, provide the seller-side contact's name, role, and preferred availability window (days/times) — used to assign escalation paths.
Timing and constraints
- Are there site-level blackout windows or planned regulatory inspections in the next 90 days that would block onboarding? If yes, list site and dates; if no, select 'No blackout windows'.
- Provide the target go-live month for the first live patient shipments and list any hard compliance gates that must be met before that date (for example: QA sign-off, customs ATP).
-
Configuration Details
Lock exact operational parameters — SOPs, monitoring thresholds, notification endpoints, customs paperwork templates, and credentials for integrations.
Configuration Details
Environments & Endpoints
- Production instance name (enter the exact instance identifier used in your environment; Default: production)
- Staging instance name (enter the exact instance identifier used for test/pre-prod; Default: staging)
- Deployment region for the instance (select the single region this build will operate in)
- Platform API base URL to use for automated telematics (format: https://api.example.com — enter full URL)
- Primary monitoring webhook endpoint (format: https://... — enter the single webhook URL the platform will post alerts to)
- System timezone used for all timestamping and reporting (Default: UTC — enter IANA tz e.g., America/New_York)
SOPs & Operational Parameters
- Authoritative SOP document identifier (enter the single document ID or version string the deployment will lock to, e.g., SOP-LOG-2026v1)
- SOP repository URL (format: https://... — enter the single URL where the SOP PDF/protocol lives)
- Primary shipment temperature profile (select the one profile that applies to the majority of your live patient shipments)
- Viability window for patient material (hours — Default: 72 — enter a single integer hours value the deployment enforces in routing and acceptance logic)
- Chain-of-identity confirmation method to be used at every handoff (select primary method)
- Acceptance criteria document ID for test shipments (enter the single identifier or file name the platform will reference when validating qualification runs)
Monitoring thresholds & Alerting
- Primary temperature excursion alert threshold (degrees Celsius — enter a numeric value; e.g., for 2–8°C network enter 8)
- Critical temperature excursion threshold that triggers immediate escalation (degrees Celsius — enter a numeric value)
- Allowed excursion duration before alert escalation (minutes — Default: 15 — enter integer minutes)
- Telemetry reporting cadence from shippers (seconds — Default: 300 — enter integer seconds between telemetry updates)
- Data retention period for telemetry and chain-of-custody logs (days — Default: 365 — enter integer days)
- Primary alert channel (select the single channel where first-line alerts are delivered)
- Primary alert destination address (enter the single value matching the channel choice above: email list, webhook URL, phone number, or PagerDuty routing key name)
Escalation & On-call Mapping
- Primary on-call role for first-response (enter role title exactly as used in your org, e.g., 'Logistics Ops Lead')
- Secondary on-call role if primary does not acknowledge (enter single role title, e.g., 'Head of Clinical Ops')
- Minutes to escalate from primary to secondary (integer minutes — Default: 30)
- Regulatory escalation role for reportable events (enter single role title responsible for regulatory notifications)
- Escalation notification method for reportable events (select one)
Chain-of-Custody & Documentation Templates
- Required document types for every shipment (select all that apply)
- Which party supplies the customs paperwork template for cross-border shipments (select one)
- Default commercial invoice language preference (select one)
- Harmonized System (HS) code to use on commercial invoices for these cellular materials (enter single code string)
- Designated customs broker for import/export (enter single broker name or 'TBD' if not yet selected)
Integrations & Non-Secret Credential Identifiers
- Identity provider type for user SSO (select one — the platform will use this to configure SSO; do not paste secrets)
- IdP entity ID / issuer value (enter the single entity ID string the platform will reference; leave blank if 'No SSO')
- TMS (transport management system) integration type for routing (select one)
- Integration client identifier (non-secret) for the chosen TMS or EHR connector (enter client ID or integration user name; do not paste secrets)
- Credential owner and hand-off method for secrets (enter single person/role who owns secrets AND select how the secret will be exchanged securely)
- Name of the team that will operate the integration once live (enter single team name, e.g., 'Clinical Logistics Ops')
Pre-Deployment Credentials & Gateways (identifiers only)
- Name of the integration user account for shipper telematics (enter the single username that will be used; do not supply password/token)
- Name of the integration user account for customs/clearance portal (enter the single username that will be used; do not supply credentials)
- Which secrets manager will hold deployment secrets (select one — used to coordinate secure exchange)
- Approved secure channel for initial secret handover (select one)
Roles, Acceptance & Go-Live Gates
- Role/title for Go/No-Go sign-off for first live patient shipment (enter single role title)
- Role/title responsible for final regulatory acceptance before live ops (enter single role title)
- Number of successful qualification test shipments required to pass acceptance (integer — Default: 3)
- Maximum open compliance findings allowed at go-live (integer — Default: 0)
- Documentation sign-off artifact name required at go-live (enter single artifact identifier, e.g., 'GoLive-Signoff-v1')
Operational Limits, Reporting & Maintenance
- Maximum concurrent live patient shipments allowed by this deployment (integer — Default: 50)
- Maximum allowed shipper downtime before reroute/hold (hours — Default: 4)
- Scheduled reporting cadence for operational dashboards (days — Default: 7)
- Calibration/maintenance interval for temperature monitoring hardware (days — Default: 180)
Final Mapping & Overrides
- Field name in buyer systems for patient identifier (enter the single field/key the platform should map to)
- Field name in buyer systems for shipment identifier (enter the single field/key the platform should map to)
- Timezone override for a specific site (enter 'site identifier — IANA timezone', or 'None' if not required)
- Single ticketing queue identifier for incident tracking (enter the single queue name or 'None' if external ticketing will be used)
-
Deployment
Execute onboarding tasks, site qualifications, training, and the phased rollout plan with named owners and escalation paths.
-
Go-Live Acceptance
Formal go/no-go gate: verify acceptance criteria for first live patient shipments, confirm no open compliance issues, and sign off named owners before full operations.
Checklist items
- Obtain formal acceptance-signoff of first-live shipment acceptance criteria
- Receive regulatory closure memo for shipment-related findings
- Collect named owner delegation and escalation roster
- Confirm go/no-go and abort procedure document is signed
- Validate customs and cross-border documentation for planned routes
- Verify monitoring integrations and notification endpoints with an end-to-end test
- Approve chain-of-identity and chain-of-custody templates and sample completed log
- Assemble and inspect first-patient shipment kit
- Obtain completed training competency records for all named site and courier staff
- Validate emergency return and alternate-receipt agreements and perform a tabletop or tested handoff
- Hold final go/no-go review and secure formal go/no-go sign-off document
-
-
Success
Monitor outcome metrics, review incidents and corrective actions, and maintain a shared backlog for continuous improvement.
Success Reviews
- Go-Live Health Check (weeks 1-4)
- First Measurement Review (weeks 4-10)
- Acceptance Gate Meeting (day ~90)
- Monthly Operational Review (ongoing, monthly)
- Quarterly Business Review (ongoing, quarterly)
- Annual Outcomes Review (annual)
Issues & Enhancements
- Ensure all regulatory or compliance issues are tracked with remediation plans and are on schedule.
- Operational metric snapshot
- Confirm monthly trajectory for temperature excursion rate and chain-of-identity error rate and capture required adjustments if off-target.
- Ensure all incidents have defined corrective actions with resolution dates recorded in the shared backlog.
- Agree the top backlog items to execute in the next month and their acceptance criteria.
- Update the continuous-improvement backlog with incident remediation tasks, priority, and target completion dates.
- Schedule technical or process change windows required to address any recurring incident root causes.
- Produce a one-page monthly operational summary for distribution to named owners.
- Quarterly KPI review
- Confirm whether on-time delivery within the viability window and average customs delay hours per cross-border shipment meet the targets recorded in Test Shipments Evaluation.
- Re-confirm committed success criteria and owners
- Agree the prioritized quarterly backlog that will materially improve KPI outcomes.
- Publish the quarterly KPI dashboard with supporting evidence and share with operational and compliance owners.
- Open project tickets for systemic fixes identified in the trend analysis, with success criteria and timelines.
- Prepare an audit-readiness checklist and schedule any required corrective documentation updates.
- Annual performance summary
- Confirm annual achievement versus targets for temperature excursion rate and first-pass acceptance rate for qualification shipments as recorded in Test Shipments Evaluation.
- Verify which corrective actions were effective and determine remaining high-impact items for the upcoming year.
- Finalize the 12-month backlog and success criteria for each major initiative.
- Deliver the annual performance report with metric trends, incident summaries, and corrective action outcomes.
- Create project charters for the agreed high-impact backlog items with measurable success criteria and timelines.
- Compile and validate updated regulatory documentation and accreditations required for the next 12 months.
- Deployment artifacts and runbooks are verified as active in the buyer's scenarios.
- All critical early blockers are recorded with remediation actions and target dates.
- Data sources and delivery format for the first measurement meeting are confirmed.
- Publish a short deployment verification checklist with status for each site and integration.
- Capture and circulate the list of open blockers with proposed remediation steps and target resolution dates.
- Provide the dataset specification and delivery schedule for the first measurement meeting.
- Present first shipment performance data
- Establish whether temperature excursion rate and on-time delivery within the viability window are on track to meet targets recorded in Test Shipments Evaluation.
- Deliver a prioritized remediation plan with specific tasks and resolution dates for each metric shortfall.
- Confirm the dataset and evidence required for the Acceptance Gate meeting.
- Produce a root-cause action list for each metric gap with task-level remediation and target completion dates.
- Collect and validate the evidence package required for the Acceptance Gate, including shipment logs, monitoring traces, and chain-of-custody records.
- Schedule an interim technical fix window if any urgent equipment or integration changes are required.
- Restate acceptance criteria and numeric targets
- Arrive at a documented acceptance decision for each recorded criterion in Test Shipments Evaluation.
- Confirm the incumbent system is decommissioned or formally retained read-only, with data archived and fallback processes closed.
- Agree remediation actions and a timeline to address any conditional or failed acceptance items.
- Publish the formal acceptance record showing pass/fail per criterion and store the evidence package alongside it.
- Execute the incumbent decommission checklist or retention plan, including contract termination steps, data archival verification, and communication to operational teams.
- Create a tracked remediation register for any conditional items with target resolution dates and required evidence.
- Deployment and process validation
- Present aggregated outcome data against each criterion
- Compare results to targets in Test Shipments Evaluation
- Compliance and audit readiness review
- Review of corrective action effectiveness
- Incident reviews and corrective action status
- Pass/fail determination and documented decision
- Backlog and roadmap for the next 12 months
- Root cause analysis for any shortfalls
- Early operational signals
- Backlog triage and prioritization
- Incident trend analysis
- Backlog roadmap alignment
- Agree corrective actions and timelines
- Incumbent wind-down confirmation
- Blockers and escalation items
- Open issues and immediate remediation
- Regulatory posture and documentation health